Peritoneal Cancer - Pipeline Review, H2 2013

Global Markets Directs, Peritoneal Cancer - Pipeline Review, H2 2013, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Peritoneal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Peritoneal Cancer. Peritoneal Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

A snapshot of the global therapeutic scenario for Peritoneal Cancer.

A review of the Peritoneal Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Coverage of products based on various stages of development ranging from discovery till registration stages.

A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Coverage of the Peritoneal Cancer pipeline on the basis of route of administration and molecule type.

Key discontinued pipeline projects.

Latest news and deals relating to the products.

Reasons to buy

Identify and understand important and diverse types of therapeutics under development for Peritoneal Cancer.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Checkpoint Inhibitors for Treating Cancer in these

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Anti-Cancer Injectable in these regions, from 2012

The global Specific Cancer Immunotherapy Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
The Asia-Pacific will occupy for more market share in following years, especially in China, also f

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Excipients in these regions, from 2012 to 2022 (for

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Sofosbuvir in these regions, from 2012 to 2022 (for

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Pharmaceutical Packaging Aluminum Foil in these reg